NCT05349201

CAR-T Cells - Real Life Study Of Care Pathway And Total Cost Of Care For Patients Under Car T-Cell Treatment Based On The PMSI French Database

Study Summary

This was a Retrospective cohort study based on the PMSI data source

Want to learn more about this trial?

Request More Info

Interventions

KYMRIAHOTHER

Patients (≥18 years of age) with (relapsed/refractory diffuse large B cell lymphoma \[R/R DLBCL\]) or Pediatric and young adult patients (≤25 years of age) with B cell acute lymphoblastic leukemia (ALL) refractory, in relapse post transplant or in second or later relapse

YESCARTAOTHER

Patients (≥18 years of age) with (relapsed/refractory diffuse large B cell lymphoma \[R/R DLBCL\])

Study Locations

Facility	City	State	Country
Novartis Investigative Site	East Hanover	New Jersey	United States

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026